Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 27, Issue 1

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 27, Issue 1 (2018)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 27, Issue 1 (2018)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Volume 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

PI3K inhibition to overcome endocrine resistance in breast cancer

Niamh M Keegan, Jack P Gleeson, Bryan T Hennessy & Patrick G Morris

Pages: 1-15

Published online: 06 Jan 2018

AbstractforPI3K inhibition to overcome endocrine resistance in breast cancer | Full Text | References | PDF (1.6 MB)

1073 Views
1 CrossRef citations
0Altmetric

Review

MEK inhibitors under development for treatment of non-small-cell lung cancer

Chul Kim & Giuseppe Giaccone

Pages: 17-30

Published online: 13 Dec 2017

AbstractforMEK inhibitors under development for treatment of non-small-cell lung cancer | Full Text | References | PDF (1.2 MB)

1165 Views
48 CrossRef citations
0Altmetric

Review

Bruton’s tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL)

Philip A Thompson & Jan A Burger

Pages: 31-42

Published online: 15 Nov 2017

AbstractforBruton’s tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL) | Full Text | References | PDF (1,011.6 KB)

1651 Views
48 CrossRef citations
0Altmetric

Review

Investigational drugs in clinical trials for Hidradenitis Suppurativa

Peter Theut Riis, Linnea R. Thorlacius & Gregor B. Jemec

Pages: 43-53

Published online: 04 Dec 2017

AbstractforInvestigational drugs in clinical trials for Hidradenitis Suppurativa | Full Text | References | PDF (1,009.4 KB)

1402 Views
33 CrossRef citations
0Altmetric

Review

Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome

Andres Chang, Danielle Schlafer, Christopher R. Flowers & Pamela B. Allen

Pages: 55-70

Published online: 24 Dec 2017

AbstractforInvestigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome | Full Text | References | PDF (1.2 MB)

415 Views
1 CrossRef citations
0Altmetric

Review

New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds

Gerasimos Dimitropoulos, S. M. Zubair Rahim, Alexandra Sophie Moss & Gregory Y. H. Lip

Pages: 71-86

Published online: 14 Dec 2017

AbstractforNew anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds | Full Text | References | PDF (1.3 MB)

323 Views
1 CrossRef citations
0Altmetric

Review

Investigational drugs in phase I and phase II clinical trials for hereditary angioedema

Henriette Farkas, Márta Lídia Debreczeni & Kinga Viktória Kőhalmi

Pages: 87-103

Published online: 15 Dec 2017

AbstractforInvestigational drugs in phase I and phase II clinical trials for hereditary angioedema | Full Text | References | PDF (1.2 MB)

393 Views
1 CrossRef citations
0Altmetric

Drug Evaluation

Article

Alisertib: a review of pharmacokinetics, efficacy and toxicity in patients with hematologic malignancies and solid tumors

Susanne Liewer & Ashley Huddleston

Pages: 105-112

Published online: 03 Jan 2018

AbstractforAlisertib: a review of pharmacokinetics, efficacy and toxicity in patients with hematologic malignancies and solid tumors | Full Text | References | PDF (658 KB)

1017 Views
1 CrossRef citations
0Altmetric

Article

Gabapentin for the treatment of alcohol use disorder

Barbara J. Mason, Susan Quello & Farhad Shadan

Pages: 113-124

Published online: 23 Dec 2017

AbstractforGabapentin for the treatment of alcohol use disorder | Full Text | References | PDF (1.1 MB)

1840 Views
3 CrossRef citations
0Altmetric

Article

Roxadustat in the treatment of anaemia in chronic kidney disease

Lucia Del Vecchio & Francesco Locatelli

Pages: 125-133

Published online: 25 Dec 2017

AbstractforRoxadustat in the treatment of anaemia in chronic kidney disease | Full Text | References | PDF (814.5 KB)

1681 Views
1 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.27, Iss.1, 2018)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?